Xcout Intel
Mytos, Inc.
Mytos is a biotechnology research and automation company headquartered in London, United Kingdom. Its automation technology enables faster cell culture scaling and cleanroom batch production at a lower cost.
Subscribe to see Mytos, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Mytos, Inc. at a glance
Mytos, Inc. is a biotech company headquartered in London, United Kingdom, founded in 2018. Its most recent funding round raised $18M in September 2023. Xcout tracks 7 named people at Mytos, Inc., including Ali Afshar (CEO and Co-Founder). Xcout recorded 13 job postings from Mytos, Inc. in the last 90 days.
Mytos, Inc. leadership
- Ali AfsharCEO and Co-Founder
- Ignacio WillatsCCO and Co-Founder
- James CunninghamHead of Special Projects
- Justin ChanHead of Engineering
- Dr. Xian WengDirector of Product
- Ali AfsharExecutive Officer
1 more named person on record for Mytos, Inc., with roles, board committees and tenure — see the full roster →
Mytos, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $18M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Mytos, Inc.
Xcout recorded 13 job postings from Mytos, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Mytos, Inc.'s hiring signals →
Mytos, Inc. competitors
A few of Mytos, Inc.'s closest competitors — see the full list of competitors and alternatives →
CellBri is a cell therapy automation company that develops closed-system, cGMP-ready platforms for manufacturing CAR-T, NK, TCR-T, and stem cells without vendor lock-in.
Culture Biosciences, Inc. is a biotechnology company that provides digital biomanufacturing and bioreactor systems for scaling cell culture processes. Founded by Matthew Ball and Will Patrick, the active firm operates in the life sciences sector.
ChainReactor Technologies provides infrastructure for industrial biology by combining physical AI, process engineering, and patented advanced manufacturing. The company offers modular benchtop bioreactors and a large biological model to help biomanufacturers predict cell behavior and test processes at scale before commercial production.
CellFiber Co., Ltd. is a Japanese biotechnology company headquartered in Tokyo that specializes in cell encapsulation technology. The company develops innovative bio-manufacturing platforms and operates international subsidiaries to support biomedical applications.
Kytopen Corp. is a biotechnology company focused on cell therapy discovery, with facilities located in Cambridge, Massachusetts, and Louisville, Colorado, as well as an international expansion in Germany.
Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Get Mytos, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Mytos, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Mytos, Inc. in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access